(Q22241923)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

0 references

1 reference

coronary artery disease

1 reference

1

P. W. F. Wilson

Wilson PW

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

Ralph B. D'Agostino Sr.

series ordinal

2

object named as

R. B. D'Agostino

D'Agostino RB

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

6

W. B. Kannel

Kannel WB

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

3

D. Levy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

author name string

A. M. Belanger

series ordinal

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

H. Silbershatz

series ordinal

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

19 May 1998

0 references

12 May 1998

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

volume

97

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

page(s)

1837-1847

0 references

1837-47

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

30 April 2017

issue

18

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9603539

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Estrogen and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Blood lipid measurements. Variations and practical utility

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Parental history is an independent risk factor for coronary artery disease: the Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

High-density lipoprotein, low-density lipoprotein and coronary artery disease

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

The distribution of plasma lipoproteins in middle-aged male runners

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Have expert panel guidelines kept pace with new concepts in hypertension?

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

An investigation of coronary heart disease in families. The Framingham offspring study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Leisure time physical activity in the Framingham Offspring Study. Description, seasonal variation, and risk factor correlates

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

A meta-analysis of physical activity in the prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Physical activity and the incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

National Education Programs Working Group report on the management of patients with hypertension and high blood cholesterol

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Cholesterol and coronary heart disease: predicting risks by levels and ratios

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021

Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.97.18.1837

7 January 2021